Y. Tanigawara et al., POPULATION PHARMACOKINETICS OF THEOPHYLLINE .3. PREMARKETING STUDY FOR A ONCE-DAILY ADMINISTERED PREPARATION, Biological & pharmaceutical bulletin, 18(11), 1995, pp. 1590-1598
The population pharmacokinetic parameters for a once-daily administere
d preparation, Uniphyl,were estimated from data collected in the prema
rketing clinical trial, Altogether, 2772 serum theophylline concentrat
ions were obtained from 131 normal subjects and 306 patients suffering
from chronic asthma or chronic obstructive pulmonary disease who part
icipated in the phase I, II, and III clinical trials in Japan, The ser
um concentration profile was described by a linear one-compartment mod
el with first-order absorption, The factors affecting the pharmacokine
tics of this drug were examined by the likelihood ratio test using a n
onlinear mixed effect model (NONMEM). The first-order absorption rate
constant (Ka) for a 200-mg tablet in a fasting condition was obtained
as 0.0773 (1/h), which was smaller than the elimination rate constant
(0.168 1/h), indicating the flip-flop characteristic of this preparati
on, Food ingestion increased the Ka by 17% and the absorption lag time
by 5-fold but did not affect the extent of absorption, The 400-mg tab
let showed a Ka value 19%, smaller than the 200-mg tablet. Children no
t older than 15 years showed 58% longer absorption lag time, The inter
-individual variability in Ka was 19%, suggesting small variability in
the in vivo release process. The total body clearance was related to
hepatic function, smoking habits, and age, Furthermore, clearance decr
eased in association with the severity of illness. The findings obtain
ed here are useful not only for the initial dosage adjustment for pati
ents with a variety of backgrounds but also for dose individualization
based on serum concentration monitoring with or without the Bayesian
feedback method.